Insider · CIK 0001202094
Kimberly Manhard
Files at INBX (Inhibrx Biosciences, Inc.). First filing Sep 10, 2026, latest Sep 15, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INBX: Inhibrx Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | INBXsell Inhibrx Biosciences, Inc. | $164k 1,500 shares | -17% | - | |
| 30Weak | INBXsell Inhibrx Biosciences, Inc. | $115k 1,000 shares | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | 25 d ago |
| Sep 11, 2026 | INBX Inhibrx Biosciences, Inc. | SOpen-market sale Common Stockindirect: Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 | -500 | $111.78 | $56k | 8,500 | 28 d ago |
| Sep 14, 2026 | INBX Inhibrx Biosciences, Inc. | SOpen-market sale Common Stockindirect: Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 | -500 | $110.26 | $55k | 8,000 | 28 d ago |
| Sep 15, 2026 | INBX Inhibrx Biosciences, Inc. | SOpen-market sale Common Stockindirect: Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 | -500 | $105.05 | $53k | 7,500 | 28 d ago |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | SOpen-market sale Common Stockindirect: Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 | -500 | $115.14 | $58k | 9,500 | 33 d ago |
| Sep 9, 2026 | INBX Inhibrx Biosciences, Inc. | SOpen-market sale Common Stockindirect: Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 | -500 | $115.80 | $58k | 9,000 | 33 d ago |
| May 28, 2025 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | May 29, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.